Kampala Region HIV Project(KHP)
- Post by: admin
- June 29, 2021
SPONSORS, FUNDERS PARTNERS: CDC/Uganda PEPFAR
With CDC/Uganda PEPFAR support, Infectious Disease Institute(IDI) is currently in partnership with JCRC to implement the Kampala Region HIV project titled “Accelerating epidemic control in Kampala Region of Uganda under PEPFAR through scale up of evidence based and high impact interventions towards achievement of UNAIDS 90:90:90 targets”.
In April 2017, IDI was awarded a 5 Year Cooperative Agreement by CDC/Uganda to accelerate epidemic control in Kampala Region through scale up of evidence based and high impact interventions towards achievement of UNAIDS 90:90:90 targets.
The Project goal is to sustain gains made and further accelerate epidemic control through scale up of evidence based and high impact interventions towards achievement of UNAIDS 90:90:90 targets; and strengthening National, regional, district, health facilities and community health structures in Kampala region of Uganda through supported health facilities in Kampala Capital City Authority and Wakiso District.
Project objectives are:
a)To increase universal access to quality HIV/AIDS services through strategic public-private partnerships, community involvement, and care differentiation across the region by 2022.
b) To increase demand, utilization, and community support for comprehensive HIV/AIDS services among KP and other vulnerable groups across the region throughout the project period.
c) To build local capacity and ownership for sustainable comprehensive service delivery by districts and indigenous organizations by 2022.
d) To strengthen Strategic Information systems to generate comprehensive, quality and timely health information for data driven programming towards UNAIDS 90:90:90 targets throughout the project period
The primary objective of this project is to accelerate HIV/AIDS epidemic control and attain the UNAIDS 90-90-90 goals using the Test and Start approach combines with efficient models of service delivery; care and treatment services and essential laboratory services, targeted HIV testing services(HTS), prevention of transmission among KPs, and Priority populations, TB/HIV prevention, diagnosis and treatment, eMTCT, and services to OVCs.